CARA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $70,932.40

Cara Therapeutics Insider Trading History Chart

Cara Therapeutics Share Price & Price History

^$0.75

▼ -0.06 (-7.41%)

As of 05/17/2024 01:00 AM ET

Days: 30 | 90 | 365

Top 5 AI Stocks to Buy for 2024

From Market Moving Trends | Ad

5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Cara Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/2/2024	Christopher Posner	CEO	Sell	3,936	$0.75	$2,952.00	176,585
4/5/2024	Joana Goncalves	Insider	Sell	2,753	$0.83	$2,284.99	53,365
2/8/2024	Christopher Posner	CEO	Sell	35,575	$0.53	$18,854.75	186,355
2/8/2024	Ryan D Maynard	CFO	Sell	5,488	$0.53	$2,908.64	8,012
2/8/2024	Scott Terrillion	Insider	Sell	7,770	$0.53	$4,118.10	94,293
2/1/2024	Christopher Posner	CEO	Sell	4,981	$0.55	$2,739.55	221,930
11/2/2023	Christopher Posner	CEO	Sell	3,796	$1.22	$4,631.12	164,411
8/3/2023	Christopher Posner	CEO	Sell	4,307	$3.07	$13,222.49	168,207
6/23/2023	Frederique Ph.D. Menzaghi	SVP	Sell	2,993	$3.51	$10,505.43	153,747
6/23/2023	Scott Terrillion	Insider	Sell	2,483	$3.51	$8,715.33	88,563
5/5/2023	Christopher Posner	CEO	Sell	3,869	$4.40	$17,023.60	172,514
4/4/2023	Frederique Ph.D. Menzaghi	SVP	Sell	2,733	$4.91	$13,419.03	156,740
4/4/2023	Scott Terrillion	Insider	Sell	2,481	$4.91	$12,181.71	91,046
2/2/2023	Christopher Posner	CEO	Sell	4,191	$11.80	$49,453.80	182,370
1/17/2023	Joana Goncalves	Insider	Sell	2,265	$10.81	$24,484.65	67,371
12/21/2022	Frederique Ph.D. Menzaghi	SVP	Sell	3,506	$11.27	$39,512.62	166,275
12/21/2022	Joana Goncalves	Insider	Sell	2,992	$11.27	$33,719.84	71,901
11/16/2022	Christopher Posner	CEO	Sell	14,470	$11.13	$161,051.10	186,561
9/14/2022	Martin Vogelbaum	Director	Sell	10,800	$10.28	$111,024.00	44,988
7/15/2022	Jeffrey L. Ives	Director	Sell	3,600	$9.05	$32,580.00	15,476
4/4/2022	Christopher Posner	CEO	Sell	2,006	$12.67	$25,416.02	201,031
4/1/2022	Frederique Ph.D. Menzaghi	SVP	Sell	1,784	$11.91	$21,247.44	169,781
4/1/2022	Scott Terrillion	Insider	Sell	1,642	$11.91	$19,556.22	74,893
3/3/2022	Scott Terrillion	Insider	Sell	1,787	$11.38	$20,336.06
3/3/2022	Thomas Charles Reilly	CFO	Sell	2,044	$11.38	$23,260.72
2/25/2022	Scott Terrillion	Insider	Sell	1,972	$10.29	$20,291.88
11/12/2021	Jeffrey L. Ives	Director	Sell	8,180	$16.04	$131,207.20
11/1/2021	Joana Goncalves	Insider	Sell	1,000	$17.15	$17,150.00
10/27/2021	Joana Goncalves	Insider	Sell	1,000	$15.00	$15,000.00
9/7/2021	Derek T. Chalmers	CEO	Sell	20,000	$15.47	$309,400.00	991,405
8/30/2021	Derek T Chalmers	CEO	Sell	8,440	$14.20	$119,848.00	1,011,405
8/30/2021	Frederique Ph.D. Menzaghi	SVP	Sell	3,847	$14.20	$54,627.40	141,072
8/30/2021	Scott Terrillion	Insider	Sell	1,759	$14.20	$24,977.80	47,900
8/30/2021	Thomas Charles Reilly	CFO	Sell	1,982	$14.20	$28,144.40
6/7/2021	Martin Vogelbaum	Director	Sell	8,640	$13.05	$112,752.00	28,800

Top 5 AI Stocks to Buy for 2024

From Market Moving Trends | Ad

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

SEC Filings (Institutional Ownership Changes) for Cara Therapeutics (NASDAQ:CARA)

44.66% of Cara Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cara Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/10/2024	Acadian Asset Management LLC	334,231	$0.30M	0.0%	-7.3%	0.611%
5/10/2024	Vanguard Group Inc.	2,481,258	$2.26M	0.0%	-5.7%	4.539%
5/7/2024	Marquette Asset Management LLC	94,238	$86K	0.0%	N/A	0.172%
4/25/2024	Rosalind Advisors Inc.	1,548,893	$1.41M	1.3%	N/A	2.833%
1/31/2024	Federated Hermes Inc.	831,849	$0.62M	0.0%	+3.5%	1.527%
1/30/2024	Mackenzie Financial Corp	53,678	$40K	0.0%	+71.2%	0.099%
1/17/2024	Assenagon Asset Management S.A.	167,838	$0.13M	0.0%	+155.8%	0.308%
12/6/2023	Citigroup Inc.	44,821	$75K	0.0%	-24.0%	0.082%
12/1/2023	B. Riley Wealth Advisors Inc.	55,648	$93K	0.0%	-64.1%	0.102%
11/13/2023	Algert Global LLC	58,750	$99K	0.0%	N/A	0.109%
11/13/2023	Clearbridge Investments LLC	971,610	$1.63M	0.0%	-2.7%	1.797%
11/13/2023	Acadian Asset Management LLC	228,675	$0.38M	0.0%	N/A	0.423%
11/6/2023	Assenagon Asset Management S.A.	65,608	$0.11M	0.0%	N/A	0.121%
10/25/2023	Mackenzie Financial Corp	31,349	$51K	0.0%	N/A	0.058%
10/24/2023	Bank of New York Mellon Corp	165,252	$0.28M	0.0%	-12.6%	0.306%
10/24/2023	Pinnacle Associates Ltd.	649,253	$1.09M	0.0%	-3.4%	1.201%
10/18/2023	IQ EQ FUND MANAGEMENT IRELAND Ltd	848,845	$1.43M	0.3%	+904.2%	1.570%
10/13/2023	SG Americas Securities LLC	67,954	$0.11M	0.0%	+36.1%	0.126%
9/21/2023	Barclays PLC	9,346	$26K	0.0%	-67.1%	0.017%
9/7/2023	Jag Capital Management LLC	11,235	$32K	0.0%	N/A	0.021%
8/15/2023	Bain Capital Life Sciences Investors LLC	934,898	$2.65M	0.3%	-57.6%	1.729%
8/14/2023	Shay Capital LLC	12,500	$35K	0.0%	N/A	0.023%
8/14/2023	Graham Capital Management L.P.	19,168	$54K	0.0%	N/A	0.035%
8/11/2023	Jag Capital Management LLC	11,235	$32K	0.0%	N/A	0.021%
8/11/2023	Clearbridge Investments LLC	998,074	$2.83M	0.0%	+105.6%	1.846%
8/7/2023	Principal Financial Group Inc.	17,900	$51K	0.0%	-93.6%	0.033%
8/7/2023	Mirabella Financial Services LLP	14,257	$40K	0.0%	N/A	0.026%
7/27/2023	B. Riley Wealth Advisors Inc.	154,990	$0.44M	0.0%	+218.6%	0.287%
7/27/2023	Pinnacle Associates Ltd.	672,440	$1.90M	0.0%	-1.0%	1.246%
7/24/2023	Allspring Global Investments Holdings LLC	22,158	$63K	0.0%	+2,846.5%	0.041%
7/18/2023	Allspring Global Investments Holdings LLC	22,158	$63K	0.0%	+2,846.5%	0.041%
7/18/2023	Rothschild Investment Corp IL	15,100	$43K	0.0%	-46.8%	0.028%
7/10/2023	SG Americas Securities LLC	49,932	$0.14M	0.0%	-33.5%	0.093%
5/16/2023	Bain Capital Life Sciences Investors LLC	2,204,449	$10.82M	1.4%	-18.2%	4.084%
5/15/2023	Kingdon Capital Management L.L.C.	1,233,000	$6.05M	1.1%	-7.5%	2.284%
5/15/2023	Farallon Capital Management LLC	1,995,370	$9.80M	0.1%	-3.8%	3.697%
5/12/2023	Clearbridge Investments LLC	485,535	$2.38M	0.0%	+18.8%	0.900%
5/11/2023	ExodusPoint Capital Management LP	213,644	$1.05M	0.0%	-42.5%	0.396%
5/8/2023	Federated Hermes Inc.	184,349	$0.91M	0.0%	N/A	0.342%
5/5/2023	Pinnacle Associates Ltd.	679,413	$3.34M	0.1%	-1.2%	1.259%
5/2/2023	Yousif Capital Management LLC	26,035	$0.13M	0.0%	-9.4%	0.048%
5/1/2023	Virtu Financial LLC	20,582	$0.10M	0.0%	N/A	0.038%
5/1/2023	Texas Permanent School Fund Corp	48,495	$0.24M	0.0%	+89.3%	0.090%
4/28/2023	SG Americas Securities LLC	75,067	$0.37M	0.0%	+56.2%	0.139%
4/24/2023	Rothschild Investment Corp IL	28,400	$0.14M	0.0%	-51.9%	0.053%
4/24/2023	Penserra Capital Management LLC	160,290	$0.79M	0.0%	-9.2%	0.297%
3/15/2023	B. Riley Wealth Advisors Inc.	46,148	$0.50M	0.0%	+4.5%	0.086%
2/14/2023	Penserra Capital Management LLC	176,486	$1.90M	0.0%	+1.6%	0.328%
2/13/2023	ExodusPoint Capital Management LP	371,262	$3.99M	0.1%	+184.4%	0.691%
2/13/2023	Martingale Asset Management L P	39,039	$0.42M	0.0%	+233.7%	0.073%
2/10/2023	New York Life Investment Management LLC	46,688	$0.50M	0.0%	+12.7%	0.087%
2/10/2023	Clearbridge Investments LLC	408,738	$4.39M	0.0%	-6.4%	0.761%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	22,574	$0.24M	0.0%	+14.0%	0.042%
2/9/2023	Victory Capital Management Inc.	161,020	$1.73M	0.0%	+33.5%	0.300%
2/9/2023	Principal Financial Group Inc.	284,658	$3.06M	0.0%	-3.3%	0.530%
2/9/2023	Citigroup Inc.	74,090	$0.80M	0.0%	+1.3%	0.138%
2/8/2023	IQ EQ FUND MANAGEMENT IRELAND Ltd	76,325	$0.82M	0.2%	+5.2%	0.142%
2/8/2023	Swiss National Bank	110,200	$1.18M	0.0%	+2.0%	0.205%
2/7/2023	Texas Permanent School Fund	25,615	$0.28M	0.0%	-20.5%	0.048%
2/7/2023	Fox Run Management L.L.C.	13,811	$0.15M	0.1%	N/A	0.026%
2/7/2023	LPL Financial LLC	175,852	$1.89M	0.0%	-1.2%	0.327%
2/6/2023	Los Angeles Capital Management LLC	54,170	$0.58M	0.0%	-43.2%	0.101%
2/2/2023	SG Americas Securities LLC	48,067	$0.52M	0.0%	+3.7%	0.089%
2/2/2023	Cypress Capital Management LLC WY	5,350	$57K	0.1%	-28.1%	0.010%
2/2/2023	Intrepid Financial Planning Group LLC	11,500	$0.12M	0.1%	-20.7%	0.021%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	7,610	$82K	0.0%	+29.3%	0.014%
2/1/2023	Pinnacle Associates Ltd.	687,885	$7.39M	0.2%	-2.5%	1.280%
1/31/2023	Everence Capital Management Inc.	11,140	$0.12M	0.0%	N/A	0.021%
1/30/2023	New York State Common Retirement Fund	30,979	$0.33M	0.0%	+19.2%	0.058%
1/26/2023	Comerica Bank	26,629	$0.29M	0.0%	-21.5%	0.050%
1/25/2023	Pinnacle Associates Ltd.	710,692	$7.95M	0.2%	+0.8%	1.323%
1/19/2023	Rothschild Investment Corp IL	59,000	$0.63M	0.1%	+1.9%	0.110%
1/12/2023	Assenagon Asset Management S.A.	101,544	$1.09M	0.0%	+210.5%	0.189%
1/9/2023	Yousif Capital Management LLC	28,735	$0.31M	0.0%	-33.4%	0.053%
11/15/2022	Disciplined Growth Investors Inc. MN	1,700,230	$15.91M	0.4%	+0.1%	3.164%
11/15/2022	Martingale Asset Management L P	11,700	$0.11M	0.0%	-53.8%	0.022%
11/15/2022	Brandywine Global Investment Management LLC	43,336	$0.41M	0.0%	-3.7%	0.081%
11/14/2022	Tudor Investment Corp Et Al	133,603	$1.25M	0.0%	+40.4%	0.249%
11/14/2022	PDT Partners LLC	25,257	$0.24M	0.0%	-37.8%	0.047%
11/14/2022	Penserra Capital Management LLC	173,686	$1.63M	0.0%	-12.6%	0.323%
11/14/2022	MML Investors Services LLC	43,147	$0.40M	0.0%	+170.6%	0.080%
11/14/2022	Altium Capital Management LP	193,000	$1.81M	0.7%	-45.4%	0.359%
11/14/2022	MetLife Investment Management LLC	26,781	$0.25M	0.0%	+13.5%	0.050%
11/10/2022	ExodusPoint Capital Management LP	130,521	$1.22M	0.0%	+3.0%	0.243%
11/8/2022	Mutual of America Capital Management LLC	8,978	$84K	0.0%	+26.3%	0.017%
11/8/2022	New York State Common Retirement Fund	26,000	$0.24M	0.0%	+26.1%	0.048%
11/7/2022	Jump Financial LLC	35,200	$0.33M	0.0%	-19.1%	0.066%
11/4/2022	Prudential Financial Inc.	45,732	$0.43M	0.0%	+4.7%	0.085%
11/3/2022	Royce & Associates LP	214,157	$2.01M	0.0%	+113.0%	0.399%
11/3/2022	Barclays PLC	17,696	$0.17M	0.0%	-49.8%	0.033%
11/2/2022	Los Angeles Capital Management LLC	95,440	$0.89M	0.0%	+39.6%	0.178%
11/2/2022	Victory Capital Management Inc.	120,610	$1.13M	0.0%	-9.8%	0.224%
11/2/2022	Lisanti Capital Growth LLC	159,225	$1.49M	0.2%	N/A	0.296%
11/2/2022	Oregon Public Employees Retirement Fund	14,976	$0.14M	0.0%	+7.8%	0.028%
11/1/2022	Great West Life Assurance Co. Can	58,224	$0.55M	0.0%	+43.6%	0.108%
11/1/2022	Pinnacle Associates Ltd.	705,367	$6.60M	0.2%	-5.0%	1.313%
11/1/2022	Patriot Financial Group Insurance Agency LLC	12,095	$0.11M	0.0%	-29.0%	0.023%
10/31/2022	SG Americas Securities LLC	46,366	$0.43M	0.0%	-28.6%	0.086%
10/31/2022	Alpine Woods Capital Investors LLC	171,423	$1.61M	0.2%	-0.7%	0.319%
10/28/2022	New York State Teachers Retirement System	86,344	$0.81M	0.0%	+10.1%	0.161%

Data available starting January 2016

Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.

Today's Range

Now: $0.75

$0.75

$0.80

50 Day Range

MA: $0.80

$0.66

$0.95

52 Week Range

Now: $0.75

$0.50

$4.45

Volume

253,065 shs

Average Volume

280,610 shs

Market Capitalization

$41.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.74

Who are the company insiders with the largest holdings of Cara Therapeutics?: Cara Therapeutics' top insider investors include:
Christopher Posner (CEO)
Frederique PhD Menzaghi (SVP)
Scott Terrillion (Insider)
Joana Goncalves (Insider)
Martin Vogelbaum (Director)
Jeffrey L Ives (Director)
Ryan D Maynard (CFO)
Learn More about top insider investors at Cara Therapeutics.
Who are the major institutional investors of Cara Therapeutics?: Cara Therapeutics' top institutional investors include:
Vanguard Group Inc. — 4.54%
Rosalind Advisors Inc. — 2.83%
Acadian Asset Management LLC — 0.61%
Marquette Asset Management LLC — 0.17%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Cara Therapeutics stock.
Which institutional investors are selling Cara Therapeutics stock?: During the last quarter, CARA stock was sold by these institutional investors:
Vanguard Group Inc.
Acadian Asset Management LLC
During the previous year, company insiders that have sold Cara Therapeutics company stock include:
Christopher Posner (CEO)
Frederique PhD Menzaghi (SVP)
Scott Terrillion (Insider)
Joana Goncalves (Insider)
Martin Vogelbaum (Director)
Learn More investors selling Cara Therapeutics stock.
Which institutional investors are buying Cara Therapeutics stock?: During the previous quarter, CARA stock was purchased by institutional investors including:
Rosalind Advisors Inc.
Marquette Asset Management LLC